- Home
- M vs KRYS Comparison
M vs KRYS Comparison
Compare M & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- M
- KRYS
- Stock Information
- Founded
- M 1830
- KRYS 2015
- Country
- M United States
- KRYS United States
- Employees
- M N/A
- KRYS N/A
- Industry
- M Department/Specialty Retail Stores
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- M Consumer Discretionary
- KRYS Health Care
- Exchange
- M Nasdaq
- KRYS Nasdaq
- Market Cap
- M 4.8B
- KRYS 4.7B
- IPO Year
- M N/A
- KRYS 2017
- Fundamental
- Price
- M $19.46
- KRYS $203.26
- Analyst Decision
- M Hold
- KRYS Strong Buy
- Analyst Count
- M 10
- KRYS 9
- Target Price
- M $15.72
- KRYS $214.22
- AVG Volume (30 Days)
- M 6.9M
- KRYS 296.0K
- Earning Date
- M 11-25-2025
- KRYS 11-03-2025
- Dividend Yield
- M 3.76%
- KRYS N/A
- EPS Growth
- M 304.55
- KRYS 275.72
- EPS
- M 1.77
- KRYS 6.66
- Revenue
- M $22,701,000,000.00
- KRYS $373,164,000.00
- Revenue This Year
- M N/A
- KRYS $34.33
- Revenue Next Year
- M N/A
- KRYS $48.04
- P/E Ratio
- M $10.99
- KRYS $30.51
- Revenue Growth
- M N/A
- KRYS 54.51
- 52 Week Low
- M $9.76
- KRYS $122.80
- 52 Week High
- M $19.99
- KRYS $212.98
- Technical
- Relative Strength Index (RSI)
- M 64.78
- KRYS 70.19
- Support Level
- M $19.24
- KRYS $184.25
- Resistance Level
- M $19.99
- KRYS $191.88
- Average True Range (ATR)
- M 0.51
- KRYS 8.23
- MACD
- M 0.06
- KRYS 0.16
- Stochastic Oscillator
- M 79.21
- KRYS 67.91
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.